Psychopharmacology

Massachusetts General Hospital SAFER Criteria for Clinical Trials and Research

Desseilles, Martin MD, PhD; Witte, Janet MD, MPH; Chang, Trina E. MD, MPH; Iovieno, Nadia MD, PhD; Dording, Christina MD; Ashih, Heidi MD, PhD; Nyer, Maren PhD; Freeman, Marlene P. MD; Fava, Maurizio MD; Mischoulon, David MD, PhD

Editor(s): Wood, Julia K. MD; Editor

Author Information

From the Cyclotron Research Centre, University of Liège, Belgium (Dr. Desseilles); Clinical Trials Network & Institute (Drs. Desseilles, Witte, Chang, Iovieno, Dording, Ashih, Nyer, Freeman, Fava, and Mischoulon) and Depression Clinical and Research Program (Drs. Desseilles, Witte, Chang, Iovieno, Dording, Ashih, Nyer, Fava, and Mischoulon), Department of Psychiatry, Massachusetts General Hospital, Boston, MA; Harvard Medical School (Drs. Witte, Chang, Iovieno, Dording, Ashih, Nyer, Freeman, Fava, and Mischoulon).

Correspondence: Martin Desseilles, MD, PhD, Cyclotron Research Centre, University of Liège B30, 8 Allée du 6 Août, B-4000 LIEGE, Belgium. Email: [email protected]

Harvard Review of Psychiatry 21(5):p 269-274, September/October 2013. | DOI: 10.1097/HRP.0b013e3182a75cc7